DreaMed Diabetes Ltd

DreaMed Diabetes Ltd has 2 AI-enabled medical devices on the FDA list. The first decision was on June 12, 2018 and the most recent on July 18, 2019 (DreaMed Advisor Pro). Its most common review panel is Clinical Chemistry (2 devices).